Evidence map›Paper›PMID 34168132›Full record

ArticleNature communications2021

Indispensable epigenetic control of thymic epithelial cell development and function by polycomb repressive complex 2.

Thomas Barthlott, Adam E Handel, Hong Ying Teh, Rushika C Wirasinha, Katrin Hafen, Saulius Žuklys, Benoit Roch, Stuart H Orkin, Jean-Pierre de Villartay, Stephen R Daley and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Aire in Autoimmunity.Annual review of immunology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thomas Barthlott *Department of Biomedicine and University Children's Hospital of Basel, University of Basel, Basel, Switzerland.
Adam E Handel *Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID 0000-0001-8385-6346
Hong Ying Teh *Department of Biomedicine and University Children's Hospital of Basel, University of Basel, Basel, Switzerland.
Rushika C WirasinhaInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.
Katrin HafenDepartment of Biomedicine and University Children's Hospital of Basel, University of Basel, Basel, Switzerland.
Saulius ŽuklysDepartment of Biomedicine and University Children's Hospital of Basel, University of Basel, Basel, Switzerland.
Benoit RochGenome Dynamics in the Immune System Laboratory, INSERM UMR 1163, Université de Paris, Imagine Institute, Paris, France.
Stuart H OrkinDepartment of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Harvard Medical School, and Howard Hughes Medical Institute, Boston, MA, USA.ORCID 0000-0002-0313-152X
Jean-Pierre de VillartayGenome Dynamics in the Immune System Laboratory, INSERM UMR 1163, Université de Paris, Imagine Institute, Paris, France.ORCID 0000-0001-5987-0463
Stephen R DaleyInfection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.
Georg A HolländerDepartment of Biomedicine and University Children's Hospital of Basel, University of Basel, Basel, Switzerland. georg.hollander@paediatrics.ox.ac.uk.ORCID 0000-0002-8790-0874

Funding

Department of HealthWellcome TrustWellcome Trust 100643/Z/12/ZWellcome Trust 105045/Z/14/Z
6 · The paper itself

Abstract

Thymic T cell development and T cell receptor repertoire selection are dependent on essential molecular cues provided by thymic epithelial cells (TEC). TEC development and function are regulated by their epigenetic landscape, in which the repressive H3K27me3 epigenetic marks are catalyzed by polycomb repressive complex 2 (PRC2). Here we show that a TEC-targeted deficiency of PRC2 function results in a hypoplastic thymus with reduced ability to express antigens and select a normal repertoire of T cells. The absence of PRC2 activity reveals a transcriptomically distinct medullary TEC lineage that incompletely off-sets the shortage of canonically-derived medullary TEC whereas cortical TEC numbers remain unchanged. This alternative TEC development is associated with the generation of reduced TCR diversity. Hence, normal PRC2 activity and placement of H3K27me3 marks are required for TEC lineage differentiation and function and, in their absence, the thymus is unable to compensate for the loss of a normal TEC scaffold.

Indexed as

Epigenesis, GeneticAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell LineageEpithelial CellsFemaleMaleMiceMice, Inbred C57BLMice, TransgenicPolycomb Repressive Complex 2Receptors, Antigen, T-CellThymocytesThymus GlandEed protein, mousePolycomb Repressive Complex 2Receptors, Antigen, T-Cell

Identifiers

PMID34168132
PMCPMC8225857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.